Evaluation of CYT-108, a Recombinant Protease Inhibitor, for Treatment of Mild to Moderate Primary Osteoarthritis of the Knee

Conditions: Osteoarthritis, Knee; Osteoarthritis Interventions: Biological: CYT-108, a recombinant protease inhibitor; Other: Phosphate Buffered Saline (PBS) Sponsors: Cytonics Corporation; Southern Star Research Pty Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials